Locations
Bozeman, MT, USA · South San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Stage
Series C+
founded in
2010
Site One Therapeutics is a clinical stage company focused on developing innovative therapeutics for the peripheral nervous system. Their robust pipeline includes selective inhibitors of sodium channels and other validated targets aimed at addressing pain and sensory hyperexcitability disorders. By potentially eliminating addiction concerns associated with existing therapies, Site One positions itself uniquely in the market, targeting a significant need in pain management and offering a differentiated approach to treatment.
Something looks off?On-site & Remote